期刊文献+

甲状腺癌中p16和Rb蛋白表达及其意义 被引量:1

The significanc of p16 and Rb protein expression in thyroid carcinoma
暂未订购
导出
摘要 目的 探讨甲状腺癌中p16和Rb蛋白的表达、相互关系及其意义。方法 应用免疫组织化学SP法检测80例甲状腺癌患者组织中p16和Rb蛋白的表达情况。结果 p16和Rb总异常表达率,甲状腺腺瘤为12.5%; 80例甲状腺癌中,低度恶性组为66.7%,高度恶性组为87.0%。p16阳性率,低度恶性组为64.9%(37/57);高度恶性组为34.8%(8/23)。Rb 阳性率,低度恶性组为68.4%(39/57);高度恶性组39.1%(9/23);癌组织分化越差,p16及Rb阳性率越低。P16和Rb蛋白均阳性的肿瘤术后复发转移率低。结论 甲状腺癌的发生发展与p16和Rb蛋白缺失有关;瘤组织分化程度越差,p16和Rb蛋白丢失越多;p16和Rb蛋白均阳性的肿瘤术后复发率转移率低:p16和Rb蛋白的表达具有负相关关系,二者共同作用才能阻止瘤细胞的增殖。 Objectiue To study the expression of p16 and Rb proteins expression in thyroid carcinoma.Methods The expression of the two proteins was investigated by SP immunohistochemical technique in 80cases of thyroid carcinoma. Results The total abnormality rate of p16 and Rb protein ,in thyroidadenomas was 12.5%, in low malignance thyroid carcinoma was 66.7%, in high malignance thyroid carcinomawas 87.0%. The positive rates of p16 and Rb protein,in low malignance were 64. 9%(37/57),68.4%(39/57):in high malignance were 34. 8% (8/23), 39.1%(9/23).Higher rates of loss of p16 and Rb protein wereobserved in thyroid carcinoma than in thyroid adenomas. Conclusions (1)The loss of p16 and Rbprotein is highly related to the pathogenesis of thyroid carcinoma.(2) The lower- differentiated oftumor, the higher rates of loss of p16 and Rb protein (3) The low rates of recurrence or transfers wereobserved in groups which p16 and Rb protein were all positive. (4) Exepression of p16 inversely relatedto Rb protein.
出处 《国际医药卫生导报》 2004年第10期16-17,共2页 International Medicine and Health Guidance News
关键词 甲状腺癌 P16蛋白 RB蛋白 免疫组织化学 Thyroid carcinoma p16 protein Rb protein Immunohistochemistry
  • 相关文献

参考文献7

二级参考文献12

  • 1郑杰,周传农,萧枫,王秀琴.Rb、p16、细胞周期素D1蛋白在食管癌中的表达及其意义[J].中华病理学杂志,1996,25(6):336-339. 被引量:31
  • 2赵坡 杨光华 等.用非同位素PCR-SSCP法检测平滑肌肉瘤p53基因点突变[J].中华病理学杂志,1995,24:384-385.
  • 3卞修武,史景泉,柳凤轩.胶质瘤增殖活性和肿瘤基因蛋白表达及其意义[J].中华病理学杂志,1997,26(2):89-92. 被引量:13
  • 4Simpson J F,Am J Pathol,1997年,151卷,161页
  • 5郑杰,中华病理学杂志,1996年,25卷,336页
  • 6赵坡,中华病理学杂志,1995年,24卷,384页
  • 7Irene OLN,Edward CSL,sheung TF,et al.Prognostic significance of proliferating cell unclear antigen expression in hepatocellular carcinoma[J].Cancer,1994,73(9):2268.
  • 8春田るみ 井藤久雄 武市宜雄.甲状腺癌におけるestrogen receptor に关する免疫组织化学的探讨[J].癌の临床,1990,36(4):465-465.
  • 9Gavcia RL,Coltrera MD,Gown AM.Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixedembedded tissue,Comparison with flow cytometric analysis[J].Am J Pathol,1989,134:733.
  • 10Dierendonck JHK,Wijsman JH,Keijzer R,et al.Cell-cycle related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies,Comparison with Brd Urd labelling and Ki-67staining[J].Am J Pathol,1991,138:1165.

共引文献58

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部